about
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury.Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cellsTranslocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide.Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide.Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages.Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection.A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.Application of Nanomedicine to the CNS Diseases.Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging.Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis.A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection.Characterization of fluorescein isothiocyanate-dextrans used in vesicle permeability studies.Insertion and partition of sodium taurocholate into egg phosphatidylcholine vesicles.Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry.Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt.Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor.Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic.Nanomedicines and stroke: Toward translational researchQuantum dot-loaded PEGylated poly(alkyl cyanoacrylate) nanoparticles for in vitro and in vivo imagingSelegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganizationApplication of thermal analysis to the study of lipidic prodrug incorporation into nanocarriersSynthesis of Highly Functionalized Poly(alkyl cyanoacrylate) Nanoparticles by Means of Click ChemistryTransport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood–Brain BarrierA new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuaryNanoparticles against Alzheimer's disease: PEG-PACA Nanoparticles are able to link the Aβ-peptide and influence its aggregation kineticLiposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral routeSynthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIVNanotechnologies for drug delivery: Application to cancer and autoimmune diseasesMethodology for vesicle permeability study by high-performance gel exclusion chromatographyAnalysis of Serum Proteins by Micellar Electrokinetic Capillary Chromatography. Application to a Drug Carrier Evaluation
P50
Q27311418-6271C281-4F1C-462A-B270-BA3D2EDAC4E6Q28564452-ABE66025-AF2B-4731-AF16-D14BE50A2565Q33274548-34C3D136-B833-47E1-9ED4-0F4AB02CC77BQ33287118-D4C8D210-4649-4555-9FE5-92137B30F5A5Q33750596-2AF2DD9F-DB35-480D-BC9C-9E46A94BDBACQ33977814-5637501E-F18F-47D8-A257-4A7F933ED2C2Q34314650-8DA007E9-D08C-4A8B-988C-7C61D91018C2Q34743677-CE0AA57F-384E-4DF5-9147-662AE8B7D573Q35143516-2140C780-236D-4840-9B24-CAA0E9BA0C1AQ37413195-08312A0D-C04E-4135-8FCB-33B3866CDE02Q37668360-CF6636F2-2045-4683-87E0-1245EDB4A28FQ37863290-113B96CA-94C9-4F4A-B0B1-2602985F46C0Q39345253-3BB6DF05-3764-4B76-B083-544E0BF8E445Q39706676-20E1AC4D-1D71-4AD9-A597-4D67D29BD834Q42166603-E6FEA5B6-E91A-469B-A3B2-3C3BE0018BFEQ42485001-576C5B1A-30B5-4BCF-BE51-D4894ED34513Q43248430-8D5CA7CA-5D2D-47E3-9DAE-BDE2ACBF341DQ44196593-0358CD9E-135D-4422-9FE8-20B110C2F306Q45053364-83D66157-CD58-4F28-A742-E6B2EA7E8FC0Q45268731-9AD2A605-CA91-4135-89FB-05453651C029Q45997852-2DACCB13-D5CE-44BB-BA46-69BA70A1E502Q46331703-176207F4-AEF9-4E09-BC40-4F5B802B3185Q46489923-64B5FDC0-7828-4124-BFA3-30A4A573B5A0Q46803317-975F0E96-71FD-44F5-B0BE-05BBA9F62D2CQ53329405-9B682219-AEC9-43EC-9A10-B3ABA98D9088Q53424361-C02ED629-4878-4A50-B863-C367013E145AQ57354118-D9E91842-EEA3-4B21-B9F5-A6787DA09CF8Q57676504-E12C2DD7-D1CC-4586-BEFC-DBBEC8C814E6Q57676507-C0A0CE2F-DC6F-4FAF-902F-F29EE8554D73Q57676518-E05DEEC3-011B-4680-B95C-B774623D5FCAQ57676531-FEFED270-56EB-473B-84D7-CEFFA546DDF7Q59705969-2B611515-C86A-4E48-842A-C7A2C3266D7CQ59705984-FEFCE6EF-2570-4AC8-AF9C-42E3D61AB7E0Q59705994-A3AF6FA8-C4E6-4C68-8058-BBB625CFDFD6Q59706019-D76CF275-5EC4-4C1E-80E9-9C46A3FA0FC6Q59706021-214FADE5-4B28-4166-994E-95212BB80F41Q59706031-DCB660BC-56A2-482B-9A70-712C2450383BQ59706060-86F70E1F-E277-4845-8BB0-76C9E8F197F2Q59706063-E6503F57-8F88-4019-B2DC-9FA791E20C68
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karine Andrieux
@ast
Karine Andrieux
@en
Karine Andrieux
@es
Karine Andrieux
@nl
Karine Andrieux
@sl
type
label
Karine Andrieux
@ast
Karine Andrieux
@en
Karine Andrieux
@es
Karine Andrieux
@nl
Karine Andrieux
@sl
prefLabel
Karine Andrieux
@ast
Karine Andrieux
@en
Karine Andrieux
@es
Karine Andrieux
@nl
Karine Andrieux
@sl
P1053
P-3010-2017
P106
P21
P31
P3829
P496
0000-0002-2002-7556